Cardiogenic Shock Nursing Care Management and Study Guide

Cardiogenic shock is pump failure. The left ventricle can no longer move enough blood, perfusion collapses, and the patient deteriorates fast. Recognize it early, support output with the drugs and devices the team orders, and watch closely for the fluid overload and hypoxia that mean the heart is losing ground.

What Is Cardiogenic Shock?

Cardiogenic shock (pump failure) is diminished cardiac output that severely impairs tissue perfusion. It reflects severe left-sided heart failure.

Pathophysiology

The myocardium can no longer contract hard enough to maintain output, so stroke volume drops and each beat ejects less blood. Blood backs up behind the weakened left ventricle, raising preload and congesting the lungs. Heart rate climbs to compensate, but the faster, weaker pump cuts coronary perfusion and collateral flow. Each step adds workload and deepens left-sided failure, driving myocardial hypoxia, further falling output, and, left unchecked, decompensation and death.

Classification

Causes are coronary or noncoronary. Coronary cardiogenic shock is the more common form and shows up most often after acute myocardial infarction. Noncoronary cardiogenic shock comes from conditions that stress the myocardium or leave it pumping ineffectively.

Statistics and Incidences

Cardiogenic shock is fatal if left untreated. It complicates 5% to 10% of patients hospitalized with acute MI. Mortality historically ran 80% to 90%; with thrombolytics, better interventional procedures, and improved therapies, recent studies put it at 56% to 67%. It is more common in men than women because of their higher incidence of coronary artery disease.

Causes

Any condition causing significant left ventricular dysfunction with reduced cardiac output can trigger it. Myocardial infarction sets off compensatory mechanisms that prop up output briefly, then give way to deterioration. Myocardial ischemia does the same as oxygen demand rises on an already compromised myocardium. End-stage cardiomyopathy leaves the heart unable to pump enough blood for the body's needs.

Clinical Manifestations

Everything you see points to poor tissue perfusion. Skin is cool and clammy. Systolic blood pressure falls to 30 mmHg below baseline. The heart races (tachycardia) to compensate for low output. Respirations are rapid and shallow. Urine output under 20 mL/hour signals oliguria. Too little oxygenated blood to the brain brings mental confusion and obtundation, and cyanosis appears as oxygen delivery fails across the body.

Assessment and Diagnostic Findings

Auscultation may pick up a gallop rhythm, faint heart sounds, and, if shock follows rupture of the ventricular septum or papillary muscles, a holosystolic murmur. Pulmonary artery pressure (PAP) monitoring shows rising PAP, reflecting higher left ventricular end-diastolic pressure and resistance to afterload. Invasive arterial pressure monitoring shows hypotension from impaired ventricular ejection. ABG analysis shows metabolic acidosis and hypoxia. Electrocardiography may reveal acute MI, ischemia, or ventricular aneurysm. Echocardiography assesses left ventricular function and reveals valvular abnormalities. Enzyme levels (lactic dehydrogenase, creatine kinase, aspartate aminotransferase, and alanine aminotransferase) may confirm MI.

Medical Management

Treatment aims to restore cardiovascular status. Give oxygen to limit damage to muscle and organs. Angioplasty and stenting open the blocked artery. A balloon pump in the aorta supports blood flow and unloads the heart. Give IV morphine for chest pain. An arterial line allows accurate, continuous BP monitoring and a port for frequent arterial blood samples. Give fluids carefully and watch for signs of overload.

Pharmacologic Therapy

IV dopamine, a vasopressor, raises cardiac output, blood pressure, and renal blood flow. IV dobutamine is an inotrope that boosts myocardial contractility. Norepinephrine is a more potent vasoconstrictor used when needed. IV nitroprusside is a vasodilator paired with a vasopressor to improve output by dropping peripheral vascular resistance and reducing preload.

Surgical Management

When drug therapy and medical procedures fail, surgery is the last option. The intra-aortic balloon pump (IABP) is a mechanical-assist device inserted percutaneously or surgically through the femoral artery into the descending thoracic aorta; its inflatable balloon improves coronary artery perfusion and lowers cardiac workload.